Literature DB >> 35524952

Waning immunity against respiratory syncytial virus during the COVID-19 pandemic.

Frederic Reicherz1,2, Rui Yang Xu1,2, Bahaa Abu-Raya1,2, Abdelilah Majdoubi1,2, Christina Michalski1,2, Liam Golding1,3, Aleksandra Stojic4, Marina Vineta1,3, Madison Granoski4, Zenon Cieslak5, Anil Chacko6, Neil Desai2, Inna Sekirov7,8, David J Marchant4, Pascal M Lavoie1,2.   

Abstract

Health jurisdictions have seen a near-disappearance of Respiratory Syncytial Virus (RSV) during the first year of the COVID-19 pandemic. Over a corresponding period, we report a reduction in RSV antibody levels and neutralization in women and infants one year into the COVID-19 pandemic (February - June 2021) compared to earlier in the pandemic (May - June 2020), in British Columbia (BC), Canada. This supports that humoral immunity against RSV is relatively short-lived and its establishment in infants requires repeated viral exposure. Waned immunity in young children may explain the inter-seasonal resurgence of RSV cases in BC as seen also in other countries.
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America and HIV Medicine Association. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19 pandemic; Infants; Lower Respiratory Tract Infections; Neutralizing antibody; Respiratory Syncytial Virus

Year:  2022        PMID： 35524952      PMCID： PMC9129162          DOI： 10.1093/infdis/jiac192

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   7.759


  4 in total

1.  Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption.

Authors:  Kevin Messacar; Rachel E Baker; Sang Woo Park; Hai Nguyen-Tran; Jessica R Cataldi; Bryan Grenfell
Journal:  Lancet       Date:  2022-07-14       Impact factor: 202.731

2.  Decreased incidence followed by comeback of pediatric infections during the COVID-19 pandemic in Japan.

Authors:  Cyrus Ghaznavi; Haruka Sakamoto; Takayuki Kawashima; Sayaka Horiuchi; Masahiro Ishikane; Sarah Krull Abe; Daisuke Yoneoka; Akifumi Eguchi; Yuta Tanoue; Masahiro Hashizume; Shuhei Nomura
Journal:  World J Pediatr       Date:  2022-05-31       Impact factor: 9.186

Review 3.  Hepatitis of unknown aetiology in children - epidemiological overview of cases reported in Europe, 1 January to 16 June 2022.

Authors:  Adriana Romaní Vidal; Aisling Vaughan; Francesco Innocenti; Soledad Colombe; Lina Nerlander; Natalia Rachwal; Bruno Christian Ciancio; Aikaterini Mougkou; Carlos Carvalho; Enrique Delgado; Piers Mook; Géraldine de Muylder; Michael Peeters; Tencho Tenev; Elitsa Golkocheva-Markova; Veronika Vorobieva Solholm Jensen; Anders Koch; Julie Figoni; Cécile Brouard; Georgia Nikolopoulou; Anastasia Zisouli; Niamh Murphy; Annemarie Broderick; Lital Goldberg; Rivka Rich; Lior Hecht Sagie; Maria Elena Tosti; Barbara Suligoi; Rosa Joosten; Roan Pijnacker; Ingvild Fjeldheim; Eli Heen; Małgorzata Stępień; Piotr Polański; Rui Tato Marinho; João Vieira Martins; Carmen Varela; Ana Avellón; Emmi Andersson; Marie Jansson Mörk; Sema Mandal; Conall Watson; Laura Coughlan; Meera Chand; Claire Neill; Declan T Bradley; Kathy Li; Maureen O'Leary; Neil McInnes; Christopher J Williams; Catherine Moore; Ardiana Gjini; Erika Duffell; Richard Pebody
Journal:  Euro Surveill       Date:  2022-08

Review 4.  The effects of the COVID-19 pandemic on community respiratory virus activity.

Authors:  Eric J Chow; Timothy M Uyeki; Helen Y Chu
Journal:  Nat Rev Microbiol       Date:  2022-10-17       Impact factor: 78.297
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.